Ecovyst Inc.
No SEC Form 4 filings for $ECVT in the last 30 days.
Ecovyst (NYSE:ECVT) said integration of its Calabrian acquisition is progressing as planned, with no customer disruptions, and expects $3m to $4m in cost and revenue synergies that would lower the acquisition multiple. Q2 sales rose $74m, including $55m sulfur pass-through. It raised 2026 guidance to $1.02b-$1.06b sales and $195m-$207m adjusted EBITDA, citing Calabrian.
Ecovyst (NYSE:ECVT) reported Q2 adjusted EPS of $0.21, above the $0.19 consensus, on revenue up 42% to $250 million versus $237.48 million expected. The company raised 2026 guidance: adjusted EBITDA to $195m-$207m and revenue to $1.02b-$1.06b. It also closed an INEOS sulfur dioxide derivatives acquisition in June 2026.
Ecovyst Inc. (NYSE: ECVT) reported Q2 2026 sales of $250.0 million, up 42% year over year, and net income of $10.7 million. Adjusted EBITDA rose 27% to $53.1 million. The company completed the Calabrian sulfur dioxide acquisition on June 30, 2026 and raised full-year 2026 Adjusted EBITDA guidance to $195 million to $207 million.
Over the past 7 days, alphai's AI scored 4 news stories mentioning ECVT (Ecovyst Inc.). Coverage has skewed bullish: 4 bullish, 0 neutral, and 0 bearish.
Recent ECVT coverage spans earnings, financial news and corporate actions.
Guidance raise tied to Calabrian integration and sulfur pass-through materially changes 2026 revenue and EBITDA expectations, with leverage rising to 2.0x.
Raised full-year EBITDA and revenue outlook following a Q2 beat and a newly closed sulfur dioxide derivatives acquisition, supporting near-term estimate revisions.
Guidance raise plus acquisition contribution (Calabrian) shifts 2H earnings and cash-flow expectations.
Guidance raise plus acquisition contribution likely improves near-term earnings visibility, but leverage rose due to the Calabrian term-loan increase.
New incremental debt facility ($100M) is explicitly linked to funding the INEOS Calabrian acquisition, affecting leverage and financing risk.
alphai scores every news story that mentions ECVT with an AI model for sentiment and relevance, and aggregates insider trades from Ecovyst Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Ecovyst (NYSE:ECVT) said integration of its Calabrian acquisition is progressing as planned, with no customer disruptions, and expects $3m to $4m in cost and revenue synergies that would lower the acquisition multiple. Q2 sales rose $74m, including $55m sulfur pass-through. It raised 2026 guidance to $1.02b-$1.06b sales and $195m-$207m adjusted EBITDA, citing Calabrian.
6 min readEcovyst (NYSE:ECVT) reported Q2 adjusted EPS of $0.21, above the $0.19 consensus, on revenue up 42% to $250 million versus $237.48 million expected. The company raised 2026 guidance: adjusted EBITDA to $195m-$207m and revenue to $1.02b-$1.06b. It also closed an INEOS sulfur dioxide derivatives acquisition in June 2026.
5 min readEcovyst Inc. (NYSE: ECVT) reported Q2 2026 sales of $250.0 million, up 42% year over year, and net income of $10.7 million. Adjusted EBITDA rose 27% to $53.1 million. The company completed the Calabrian sulfur dioxide acquisition on June 30, 2026 and raised full-year 2026 Adjusted EBITDA guidance to $195 million to $207 million.
4 min readEcovyst Inc. (ECVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991-ecvt2q26earningsrele.htm EX-99.1 Document Exhibit 99.1 Ecovyst Reports Second Quarter 2026 Results and Raises 2026 Outlook WAYNE, PA, August 5, 2026 -- Ecovyst Inc. (NYSE: ECVT) (“Ecovyst” or the “Company”), a leading provider of regenerated sulfuric acid, virgin
6 min readEcovyst Inc. (ECVT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 d833981dex101.htm EX-10.1 EX-10.1 Exhibit 10.1 Execution Version FOURTH AMENDMENT AGREEMENT This FOURTH AMENDMENT AGREEMENT, dated as of June 30, 2026 (this “ Fourth Amendment ”), is entered into by and among Ecovyst Catalyst Technologies LLC, a Delaware limited liabili
4 min readLorance Sarah sold 8,450 shares of Ecovyst Inc. (ECVT) at $13.33 ($0.11M total) on 2026-06-02.
2 min readMangrove Partners IM said in an SEC filing dated May 15, 2026 that it fully exited its Ecovyst (ECVT) position, selling 5,447,873 shares in an estimated $61.53 million trade based on average Q1 pricing. The filing also shows the stake’s quarter-end value fell by $53.01 million, reflecting sales and price movement.
4 min readEcovyst has provided an adjusted EBITDA outlook of $180 million to $195 million for 2026. This announcement comes as the company plans to acquire Calabrian for an estimated $190 million, a move expected to contribute significantly to its financial performance.
3 min readHarbor Capital Advisors Inc. significantly increased its stake in Ecovyst Inc. (NYSE:ECVT) by 22.1% in the fourth quarter of the previous year, now holding 584,647 shares. Institutional investors collectively own about 86.69% of Ecovyst's stock, which recently reported strong quarterly earnings, beating expectations with an EPS of $0.28 and revenue of $199.4 million. Analysts maintain a "Moderate Buy" consensus with an average target price of $13.60, and the stock is trading near its 12-month high.
3 min readSG Americas Securities LLC significantly increased its stake in Ecovyst Inc. (NYSE:ECVT) by 938% in the fourth quarter, buying an additional 299,278 shares to own a total of 331,184 shares, valued at approximately $3.22 million. Ecovyst has a "Moderate Buy" consensus rating from analysts with an average target price of $13.60, and the company recently surpassed quarterly earnings and revenue estimates. Despite mixed analyst sentiment and a negative net margin, the company provided solid FY2026 EPS guidance.
3 min read
